New study looks at links between severity of Covid-19 and antibodies

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Paul Biris

A new study has found that there is a link between the severity of Covid-19 and the levels of antibodies patients carry after recovering from the virus.

The research conducted by Stanford Medicine shows that Covid-19 antibodies preferentially target a different part of the virus in mild cases than they do in severe cases. But all antibodies significantly decrease within months.

The team of researchers studied 254 people who were asymptomatic, had mild, or severe Covid-19. They were identified at the Stanford Health Care Clinic.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism.
Subscribe
Already a subscriber? Sign in
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
31% - 9556 votes
No
69% - 21504 votes
Vote